HEADER HYDROLASE 07-JAN-03 1NLJ TITLE CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN TITLE 2 COMPLEX WITH A COVALENT AZEPANONE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: CATHEPSIN K; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: CATHEPSIN O, CATHEPSIN X, CATHEPSIN O2; COMPND 5 EC: 3.4.22.38; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS HYDROLASE, SULFHYDRYL PROTEINASE EXPDTA X-RAY DIFFRACTION AUTHOR W.W.SMITH,C.A.JANSON,B.ZHAO REVDAT 4 16-AUG-23 1NLJ 1 REMARK LINK REVDAT 3 11-OCT-17 1NLJ 1 REMARK REVDAT 2 24-FEB-09 1NLJ 1 VERSN REVDAT 1 14-JAN-03 1NLJ 0 JRNL AUTH R.W.MARQUIS,Y.RU,S.M.LOCASTRO,J.ZENG,D.S.YAMASHITA,H.J.OH, JRNL AUTH 2 K.F.ERHARD,L.D.DAVIS,T.A.TOMASZEK,D.TEW,K.SALYERS,J.PROKSCH, JRNL AUTH 3 K.WARD,B.SMITH,M.LEVY,M.D.CUMMINGS,R.C.HALTIWANGER, JRNL AUTH 4 G.TRESCHER,B.WANG,M.E.HEMLING,C.J.QUINN,H.-Y.CHENG,F.LIN, JRNL AUTH 5 W.W.SMITH,C.A.JANSON,B.ZHAO,M.S.MCQUENEY,K.D'ALESSIO, JRNL AUTH 6 C.P.LEE,A.MARZULLI,R.A.DODDS,S.BLAKE,S.M.HWANG,I.E.JAMES, JRNL AUTH 7 C.J.GRESS,B.R.BRADLEY,M.W.LARK,M.GOWEN,D.F.VEBER JRNL TITL AZEPANONE-BASED INHIBITORS OF HUMAN AND RAT CATHEPSIN K JRNL REF J.MED.CHEM. V. 44 1380 2001 JRNL REFN ISSN 0022-2623 JRNL PMID 11311061 JRNL DOI 10.1021/JM000481X REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.5 REMARK 3 NUMBER OF REFLECTIONS : 20287 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.263 REMARK 3 FREE R VALUE : 0.295 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1999 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.49 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2626 REMARK 3 BIN FREE R VALUE : 0.2949 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 1999 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3298 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 74 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -6.81700 REMARK 3 B22 (A**2) : -6.81700 REMARK 3 B33 (A**2) : 13.63500 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.547 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.418 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.350 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.361 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : INH_DIMER.PARAM REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1NLJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-JAN-03. REMARK 100 THE DEPOSITION ID IS D_1000017981. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-MAR-00 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : SI 111 REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MAR REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20856 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.5 REMARK 200 DATA REDUNDANCY : 4.600 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : 0.08000 REMARK 200 FOR THE DATA SET : 11.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.4 REMARK 200 DATA REDUNDANCY IN SHELL : 4.00 REMARK 200 R MERGE FOR SHELL (I) : 0.23100 REMARK 200 R SYM FOR SHELL (I) : 0.23100 REMARK 200 FOR SHELL : 7.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1ATK REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.69 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.91 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% MPD, 0.1 M MES,0.1 M TRIS, PH 7.0, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+3/4 REMARK 290 4555 Y,-X,Z+1/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 26.84700 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 40.27050 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 13.42350 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 21 54.98 -94.22 REMARK 500 LEU A 139 132.55 -32.54 REMARK 500 PHE A 144 52.33 -112.58 REMARK 500 GLU A 153 -15.78 -49.85 REMARK 500 GLN A 172 -114.81 -128.64 REMARK 500 LYS A 173 44.86 -68.50 REMARK 500 ASN A 190 86.51 -69.89 REMARK 500 LYS A 200 53.72 -108.36 REMARK 500 LEU A 209 62.43 -153.28 REMARK 500 GLN B 21 54.99 -95.38 REMARK 500 GLN B 92 124.16 -170.46 REMARK 500 SER B 138 -70.15 -61.79 REMARK 500 LEU B 139 131.57 -27.95 REMARK 500 PHE B 144 53.14 -112.31 REMARK 500 SER B 146 -18.40 -141.61 REMARK 500 GLN B 172 -113.78 -130.70 REMARK 500 LYS B 173 45.15 -69.96 REMARK 500 ASN B 190 83.53 -69.16 REMARK 500 LYS B 200 55.95 -109.46 REMARK 500 LEU B 209 59.74 -152.30 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2CA A 300 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2CA B 300 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1ATK RELATED DB: PDB REMARK 900 CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH THE COVALENT REMARK 900 INHIBITOR E-64 REMARK 900 RELATED ID: 1AU0 RELATED DB: PDB REMARK 900 CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT REMARK 900 SYMMETRIC DIACYLAMINOMETHYL KETONE INHIBITOR REMARK 900 RELATED ID: 1NL6 RELATED DB: PDB REMARK 900 CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT REMARK 900 AZEPANONE INHIBITOR DBREF 1NLJ A 1 215 UNP P43235 CATK_HUMAN 115 329 DBREF 1NLJ B 1 215 UNP P43235 CATK_HUMAN 115 329 SEQRES 1 A 215 ALA PRO ASP SER VAL ASP TYR ARG LYS LYS GLY TYR VAL SEQRES 2 A 215 THR PRO VAL LYS ASN GLN GLY GLN CYS GLY SER CYS TRP SEQRES 3 A 215 ALA PHE SER SER VAL GLY ALA LEU GLU GLY GLN LEU LYS SEQRES 4 A 215 LYS LYS THR GLY LYS LEU LEU ASN LEU SER PRO GLN ASN SEQRES 5 A 215 LEU VAL ASP CYS VAL SER GLU ASN ASP GLY CYS GLY GLY SEQRES 6 A 215 GLY TYR MET THR ASN ALA PHE GLN TYR VAL GLN LYS ASN SEQRES 7 A 215 ARG GLY ILE ASP SER GLU ASP ALA TYR PRO TYR VAL GLY SEQRES 8 A 215 GLN GLU GLU SER CYS MET TYR ASN PRO THR GLY LYS ALA SEQRES 9 A 215 ALA LYS CYS ARG GLY TYR ARG GLU ILE PRO GLU GLY ASN SEQRES 10 A 215 GLU LYS ALA LEU LYS ARG ALA VAL ALA ARG VAL GLY PRO SEQRES 11 A 215 VAL SER VAL ALA ILE ASP ALA SER LEU THR SER PHE GLN SEQRES 12 A 215 PHE TYR SER LYS GLY VAL TYR TYR ASP GLU SER CYS ASN SEQRES 13 A 215 SER ASP ASN LEU ASN HIS ALA VAL LEU ALA VAL GLY TYR SEQRES 14 A 215 GLY ILE GLN LYS GLY ASN LYS HIS TRP ILE ILE LYS ASN SEQRES 15 A 215 SER TRP GLY GLU ASN TRP GLY ASN LYS GLY TYR ILE LEU SEQRES 16 A 215 MET ALA ARG ASN LYS ASN ASN ALA CYS GLY ILE ALA ASN SEQRES 17 A 215 LEU ALA SER PHE PRO LYS MET SEQRES 1 B 215 ALA PRO ASP SER VAL ASP TYR ARG LYS LYS GLY TYR VAL SEQRES 2 B 215 THR PRO VAL LYS ASN GLN GLY GLN CYS GLY SER CYS TRP SEQRES 3 B 215 ALA PHE SER SER VAL GLY ALA LEU GLU GLY GLN LEU LYS SEQRES 4 B 215 LYS LYS THR GLY LYS LEU LEU ASN LEU SER PRO GLN ASN SEQRES 5 B 215 LEU VAL ASP CYS VAL SER GLU ASN ASP GLY CYS GLY GLY SEQRES 6 B 215 GLY TYR MET THR ASN ALA PHE GLN TYR VAL GLN LYS ASN SEQRES 7 B 215 ARG GLY ILE ASP SER GLU ASP ALA TYR PRO TYR VAL GLY SEQRES 8 B 215 GLN GLU GLU SER CYS MET TYR ASN PRO THR GLY LYS ALA SEQRES 9 B 215 ALA LYS CYS ARG GLY TYR ARG GLU ILE PRO GLU GLY ASN SEQRES 10 B 215 GLU LYS ALA LEU LYS ARG ALA VAL ALA ARG VAL GLY PRO SEQRES 11 B 215 VAL SER VAL ALA ILE ASP ALA SER LEU THR SER PHE GLN SEQRES 12 B 215 PHE TYR SER LYS GLY VAL TYR TYR ASP GLU SER CYS ASN SEQRES 13 B 215 SER ASP ASN LEU ASN HIS ALA VAL LEU ALA VAL GLY TYR SEQRES 14 B 215 GLY ILE GLN LYS GLY ASN LYS HIS TRP ILE ILE LYS ASN SEQRES 15 B 215 SER TRP GLY GLU ASN TRP GLY ASN LYS GLY TYR ILE LEU SEQRES 16 B 215 MET ALA ARG ASN LYS ASN ASN ALA CYS GLY ILE ALA ASN SEQRES 17 B 215 LEU ALA SER PHE PRO LYS MET HET 2CA A 300 37 HET 2CA B 300 37 HETNAM 2CA BENZOFURAN-2-CARBOXYLIC ACID {(S)-3-METHYL-1-[3-OXO-1- HETNAM 2 2CA (PYRIDIN-2-YLSULFONYL)AZEPAN-4-YLCARBAMOYL]BUTYL}AMIDE FORMUL 3 2CA 2(C26 H30 N4 O6 S) HELIX 1 1 ARG A 8 GLY A 11 5 4 HELIX 2 2 SER A 24 GLY A 43 1 20 HELIX 3 3 SER A 49 VAL A 57 1 9 HELIX 4 4 ASP A 61 GLY A 65 5 5 HELIX 5 5 TYR A 67 ASN A 78 1 12 HELIX 6 6 ASN A 99 THR A 101 5 3 HELIX 7 7 ASN A 117 VAL A 128 1 12 HELIX 8 8 LEU A 139 PHE A 144 1 6 HELIX 9 9 ASN A 202 ILE A 206 5 5 HELIX 10 10 ARG B 8 GLY B 11 5 4 HELIX 11 11 SER B 24 GLY B 43 1 20 HELIX 12 12 SER B 49 VAL B 57 1 9 HELIX 13 13 ASP B 61 GLY B 65 5 5 HELIX 14 14 TYR B 67 ARG B 79 1 13 HELIX 15 15 ASN B 99 THR B 101 5 3 HELIX 16 16 ASN B 117 VAL B 128 1 12 HELIX 17 17 LEU B 139 PHE B 144 1 6 HELIX 18 18 ASN B 202 ILE B 206 5 5 SHEET 1 A 5 VAL A 149 TYR A 150 0 SHEET 2 A 5 TYR A 193 ALA A 197 1 O LEU A 195 N TYR A 150 SHEET 3 A 5 LYS A 176 LYS A 181 -1 N ILE A 180 O ILE A 194 SHEET 4 A 5 HIS A 162 ILE A 171 -1 N LEU A 165 O LYS A 181 SHEET 5 A 5 VAL A 5 ASP A 6 -1 N VAL A 5 O TYR A 169 SHEET 1 B 5 VAL A 149 TYR A 150 0 SHEET 2 B 5 TYR A 193 ALA A 197 1 O LEU A 195 N TYR A 150 SHEET 3 B 5 LYS A 176 LYS A 181 -1 N ILE A 180 O ILE A 194 SHEET 4 B 5 HIS A 162 ILE A 171 -1 N LEU A 165 O LYS A 181 SHEET 5 B 5 VAL A 131 ILE A 135 -1 N VAL A 131 O ALA A 166 SHEET 1 C 2 ILE A 81 ASP A 82 0 SHEET 2 C 2 LYS A 103 ALA A 105 -1 O ALA A 104 N ILE A 81 SHEET 1 D 2 TYR A 110 GLU A 112 0 SHEET 2 D 2 SER A 211 PRO A 213 -1 O PHE A 212 N ARG A 111 SHEET 1 E 5 VAL B 149 TYR B 150 0 SHEET 2 E 5 TYR B 193 ALA B 197 1 O LEU B 195 N TYR B 150 SHEET 3 E 5 LYS B 176 LYS B 181 -1 N ILE B 180 O ILE B 194 SHEET 4 E 5 HIS B 162 ILE B 171 -1 N LEU B 165 O LYS B 181 SHEET 5 E 5 VAL B 5 ASP B 6 -1 N VAL B 5 O TYR B 169 SHEET 1 F 5 VAL B 149 TYR B 150 0 SHEET 2 F 5 TYR B 193 ALA B 197 1 O LEU B 195 N TYR B 150 SHEET 3 F 5 LYS B 176 LYS B 181 -1 N ILE B 180 O ILE B 194 SHEET 4 F 5 HIS B 162 ILE B 171 -1 N LEU B 165 O LYS B 181 SHEET 5 F 5 VAL B 131 ILE B 135 -1 N VAL B 131 O ALA B 166 SHEET 1 G 2 ILE B 81 ASP B 82 0 SHEET 2 G 2 LYS B 103 ALA B 105 -1 O ALA B 104 N ILE B 81 SHEET 1 H 2 TYR B 110 GLU B 112 0 SHEET 2 H 2 SER B 211 PRO B 213 -1 O PHE B 212 N ARG B 111 SSBOND 1 CYS A 22 CYS A 63 1555 1555 2.03 SSBOND 2 CYS A 56 CYS A 96 1555 1555 2.04 SSBOND 3 CYS A 155 CYS A 204 1555 1555 2.03 SSBOND 4 CYS B 22 CYS B 63 1555 1555 2.04 SSBOND 5 CYS B 56 CYS B 96 1555 1555 2.05 SSBOND 6 CYS B 155 CYS B 204 1555 1555 2.03 LINK SG CYS A 25 C07 2CA A 300 1555 1555 1.79 LINK SG CYS B 25 C07 2CA B 300 1555 1555 1.80 SITE 1 AC1 18 GLN A 19 GLY A 23 SER A 24 CYS A 25 SITE 2 AC1 18 TRP A 26 GLU A 59 ASP A 61 GLY A 65 SITE 3 AC1 18 GLY A 66 GLN A 76 ARG A 108 ALA A 134 SITE 4 AC1 18 ALA A 137 LEU A 160 ASN A 161 HIS A 162 SITE 5 AC1 18 TRP A 184 LYS B 173 SITE 1 AC2 17 LYS A 173 GLN B 19 GLY B 23 SER B 24 SITE 2 AC2 17 CYS B 25 TRP B 26 ASP B 61 GLY B 65 SITE 3 AC2 17 GLY B 66 GLN B 76 ARG B 108 ALA B 134 SITE 4 AC2 17 ALA B 137 LEU B 160 ASN B 161 HIS B 162 SITE 5 AC2 17 TRP B 184 CRYST1 100.960 100.960 53.694 90.00 90.00 90.00 P 43 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009905 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009905 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018624 0.00000